• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺血清抗原检测在乳腺癌管理中的应用:初步报告。

Application of mammary serum antigen assay in the management of breast cancer: a preliminary report.

作者信息

Tjandra J J, Russell I S, Collins J P, Stacker S A, McKenzie I F

机构信息

Department of Pathology, University of Melbourne, Parkville, Victoria, Australia.

出版信息

Br J Surg. 1988 Aug;75(8):811-7. doi: 10.1002/bjs.1800750830.

DOI:10.1002/bjs.1800750830
PMID:3048535
Abstract

A monoclonal antibody (3E1.2) based serum test using an enzyme immunoassay has been used to determine circulating levels of the breast cancer associated antigen--mammary serum antigen (MSA). Of 157 patients with early breast cancer (stage I and II) and 199 patients with advanced breast cancer (stage III and IV), 73 per cent and 87 per cent respectively had elevated MSA levels (i.e. greater than 300 inhibition units (IU). Furthermore, 40 of 44 patients (91 per cent) had a significant fall of MSA levels with reduction in tumour load by mastectomy. In addition, there was a correlation of MSA levels with the clinical course: changes in MSA levels correlated with changes in disease status (progressive disease, stable disease, disease regression) in 54 of 61 patients and antedated disease progression or recurrence by up to 8 months in some patients; and in 32 of 36 patients (89 per cent) with no clinical evidence of recurrence MSA levels did not vary by more than 25 per cent of the original MSA value over a period of 2-15 months. MSA is therefore a useful tumour marker in the diagnosis and staging of breast cancer. There is also evidence that serial estimations of MSA levels may be used to detect subclinical recurrence and the fluctuations in MSA levels might be useful in assessing response to therapy. Furthermore, it was also noted that surgical procedures such as fine needle aspiration biopsy or incisional biopsy could lead to a rise in MSA levels.

摘要

一种基于单克隆抗体(3E1.2)的血清检测方法,采用酶免疫测定法来测定乳腺癌相关抗原——乳腺血清抗原(MSA)的循环水平。在157例早期乳腺癌患者(I期和II期)和199例晚期乳腺癌患者(III期和IV期)中,分别有73%和87%的患者MSA水平升高(即大于300抑制单位(IU))。此外,44例患者中有40例(91%)在进行乳房切除术后肿瘤负荷降低,MSA水平显著下降。另外,MSA水平与临床病程存在相关性:61例患者中有54例MSA水平的变化与疾病状态(疾病进展、病情稳定、疾病消退)的变化相关,在一些患者中,MSA水平的变化比疾病进展或复发提前多达8个月;在36例无临床复发证据的患者中,有32例(89%)在2至15个月的时间内,MSA水平的变化不超过原始MSA值的25%。因此,MSA是乳腺癌诊断和分期中一种有用的肿瘤标志物。也有证据表明,对MSA水平进行系列测定可用于检测亚临床复发,MSA水平的波动可能有助于评估治疗反应。此外,还注意到细针穿刺活检或切开活检等外科手术可能导致MSA水平升高。

相似文献

1
Application of mammary serum antigen assay in the management of breast cancer: a preliminary report.乳腺血清抗原检测在乳腺癌管理中的应用:初步报告。
Br J Surg. 1988 Aug;75(8):811-7. doi: 10.1002/bjs.1800750830.
2
Detection of mammary serum antigen in sera from breast cancer patients using monoclonal antibody 3E1.2.使用单克隆抗体3E1.2检测乳腺癌患者血清中的乳腺血清抗原。
Cancer Res. 1988 Dec 15;48(24 Pt 1):7060-6.
3
Comparison of mammary serum antigen (MSA) and CA15-3 levels in the serum of patients with breast cancer.乳腺癌患者血清中乳腺血清抗原(MSA)与CA15-3水平的比较。
Br J Cancer. 1987 Dec;56(6):820-4. doi: 10.1038/bjc.1987.297.
4
Mammary serum antigen (MSA) in advanced breast cancer.晚期乳腺癌中的乳腺血清抗原(MSA)
Breast Cancer Res Treat. 1990 Jul;16(1):23-8. doi: 10.1007/BF01806572.
5
Evaluation of MSA as a serum marker in breast cancer: a comparison with CEA.评估微卫星改变(MSA)作为乳腺癌血清标志物:与癌胚抗原(CEA)的比较。
Br J Cancer. 1988 Mar;57(3):298-303. doi: 10.1038/bjc.1988.66.
6
Comparison of mammary serum antigen (MSA) with beta 2-microglobulin (beta 2M) and carcinoembryonic antigen (CEA) assays in patients with breast cancer.乳腺癌患者乳腺血清抗原(MSA)与β2-微球蛋白(β2M)及癌胚抗原(CEA)检测结果的比较
Eur J Cancer Clin Oncol. 1988 Oct;24(10):1633-40. doi: 10.1016/0277-5379(88)90056-9.
7
Mammary serum antigen (MSA) levels as a marker for breast cancer: a survey of blood donors and patients with cancer.乳腺血清抗原(MSA)水平作为乳腺癌标志物:对献血者和癌症患者的一项调查
Dev Biol Stand. 1987;67:91-6.
8
Purification and biochemical characterisation of a novel breast carcinoma associated mucin-like glycoprotein defined by antibody 3E1.2.由抗体3E1.2鉴定的一种新型乳腺癌相关粘蛋白样糖蛋白的纯化及生化特性分析
Br J Cancer. 1989 Apr;59(4):544-53. doi: 10.1038/bjc.1989.111.
9
Factors affecting MSA levels in normal women and women with breast cancer.影响正常女性和乳腺癌女性体内MSA水平的因素。
Aust N Z J Surg. 1989 Oct;59(10):805-9. doi: 10.1111/j.1445-2197.1989.tb07013.x.
10
Comparison of mammary serum antigen assay with mammography in patients with breast cancer.乳腺癌患者乳腺血清抗原检测与乳房X线摄影术的比较。
Med J Aust. 1988 Oct 17;149(8):402-6. doi: 10.5694/j.1326-5377.1988.tb120698.x.

引用本文的文献

1
CA15-3, CASA, MSA, and TPS as diagnostic serum markers in breast cancer.CA15-3、癌抗原特异性抗原(CASA)、黏液素核心蛋白(MSA)和组织多肽特异性抗原(TPS)作为乳腺癌诊断的血清标志物。
Breast Cancer Res Treat. 1995 Jun;34(3):245-51. doi: 10.1007/BF00689716.
2
The association of mammary serum antigen (MSA) with the histopathological findings in localised breast cancer.乳腺血清抗原(MSA)与局限性乳腺癌组织病理学结果的关联。
Br J Cancer. 1988 Dec;58(6):815-7. doi: 10.1038/bjc.1988.316.
3
Purification and biochemical characterisation of a novel breast carcinoma associated mucin-like glycoprotein defined by antibody 3E1.2.
由抗体3E1.2鉴定的一种新型乳腺癌相关粘蛋白样糖蛋白的纯化及生化特性分析
Br J Cancer. 1989 Apr;59(4):544-53. doi: 10.1038/bjc.1989.111.
4
CEA and CA 15-3 in primary and recurrent breast cancer.原发性和复发性乳腺癌中的癌胚抗原(CEA)和糖类抗原15-3(CA 15-3)
World J Surg. 1990 Sep-Oct;14(5):562-5; discussion 565-6. doi: 10.1007/BF01658788.
5
Analysis of the tumour-associated antigen TAG-12 by monoclonal antibody 7A9 in normal, benign and malignant mammary tissues.用单克隆抗体7A9分析正常、良性和恶性乳腺组织中的肿瘤相关抗原TAG-12。
Virchows Arch A Pathol Anat Histopathol. 1990;416(5):411-6. doi: 10.1007/BF01605146.
6
Mammary serum antigen (MSA) in advanced breast cancer.晚期乳腺癌中的乳腺血清抗原(MSA)
Breast Cancer Res Treat. 1990 Jul;16(1):23-8. doi: 10.1007/BF01806572.